C9024 (Daunorubicin AND Cytarabine) Liposome - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

(Daunorubicin AND Cytarabine) Liposome

Brand Name:

Vyxeos

Strength:

1mg/2.27mg

HCPCS:

C9024

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antitumor Antibiotic & Antimetabolite

Minor Drug Class:

Anthracycline & Pyrimidine Analog

Oral (Y/N):

No

FDA Approval Year:

2017

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use